Get instant access to this case solution for only $15

Kevin Sharer at Amgen Sustaining the High Growth Company A & B Case Solution

Solution Id Length Case Author Case Publisher
1331 1289 Words (5 Pages) William W. George, Andrew N. McLean Harvard Business School : 406020 & 409037
This solution includes: A Word File A Word File

As apparent from the case study, Sharer feels that his ability to be adaptive and resilient during different phases of his career, particularly his stay at Amgen has allowed him to be successful at his job. In addition to these basic skills, he feels it is essential for a leader to take tough decisions when it matters, to understand the ability of his team so as to know their potential, and to be strong enough to listen to feedback from both leadership team as well as, outsiders. Some of these traits such as being resilient and involving in details were learned during the crisis phase of his career – both at MCI and Amgen while other skills such as being adaptive and communicative were absorbed during his early years when his family moved from town to town.

Following questions are answered in this case study solution

  1. What skills Sharer considers key to his performance as CEO of Amgen? What you are of origin (born leader ...) and which learns during his career (the leader is ...)? Please explain your answer.

  2. Please make a SWOT analysis (Weaknesses, Threats, Strengths, Opportunities) with the minimum variables it deems appropriate, on the decision he wants to take Sharer go from being the biotechnology company based on research that was being since its foundation in 1980 to a more market-oriented pharmaceutical company. - In view of your chart, would you have made the decision for greater market orientation? - If so, what should anticipate possible critical aspects?

  3. Sharer says Amgen wanted to enter because he recognized the potential of this company to help millions of people. Do you think this is your primary motivation during his tenure as CEO of Amgen? What would you say is the scale of values Sharer as chief executive of the company (please list five values in order of priority)?

  4. In the position of Sharer, you have made the decision to replace its 8 of 9 direct reports? Can you think of alternatives? Please explain your answer.

  5. Recalling Learning Styles Kolb, D. (Adapter, Divergent, Assimilator, Convergent) observe any developments in this regard in Sharper? Please, if so, indicate what evidence is.

  6. How would you rate, from 1 to 10 (10 being the highest score) leadership as CEO Kevin Sharer of Amgen? Explain your answer.

  7. List 3-4 learnings from this case that are especially valuable to incorporate into their management and leadership exercise.

  8. What concrete situations can start applying these lessons?

Case Analysis for Kevin Sharer at Amgen Sustaining the High Growth Company A & B Case Solution

2. Please make a SWOT analysis (Weaknesses, Threats, Strengths, Opportunities) with the minimum variables it deems appropriate, on the decision he wants to take Sharer go from being the biotechnology company based on research that was being since its foundation in 1980 to a more market-oriented pharmaceutical company. - In view of your chart, would you have made the decision for greater market orientation? - If so, what should anticipate possible critical aspects?

Strengths

  • To survive the on-going competition within the pharmaceutical industry, it would be in the interest of Amgen to become market-oriented so as to develop products as per need and to drive R&D efforts accordingly.

Weaknesses

  • The core value of being and becoming the most human-therapeutic company will be compromised as the focus will be on commercialization rather than human needs.

Opportunities

  • To expand in international markets by joint collaborations with other companies who have similar interests.

Threats

  • Research and development efforts require considerable money, which is available at the discretion of shareholders who are looking for their immediate profit so R&D budget may reduce if market orientation strategy is not adopted.

3. Sharer says Amgen wanted to enter because he recognized the potential of this company to help millions of people. Do you think this is your primary motivation during his tenure as CEO of Amgen? What would you say is the scale of values Sharer as chief executive of the company (please list five values in order of priority)?

There is absolutely no doubt that one of the initial attractions for Sharer while joining Amgen was the company’s contribution in the field and towards improving the quality of life; however, as he became the CEO, the humanitarian perspective took a back seat as he was more accountable for the immediate growth and development of the company and it wasn’t his primary motivation as a CEO, which is apparent from the protest against the revision of FDA guidelines.

Values shared by Sharer in order of priority include;

  1. Being accountable

  2. Ability of employees to grow with the firm (being highly competitive)

  3. Being flexible (adaptive and resilient during times of crisis)

  4. Becoming the best company in the industry

  5. Creating value for the stakeholders

4. In the position of Sharer, you have made the decision to replace its 8 of 9 direct reports? Can you think of alternatives? Please explain your answer.

One possible alternative available to Sharer was to give at least 9 to 15 months to the current team of leadership so as to allow them to show their potential of growing with the firm. A thorough replacement of the top leadership team not only demotivates them but also makes the middle tier skeptical about their potential growth opportunities. Sharer learnt his lesson with time as he was given adequate time by the board of directors to replace the former CEO, similarly, Sharer could have given some time to the top team and could have also given them periodic feedback to improve themselves and rise to the need of the company. At present, he is considering the motivation of functional managers if he appoints a COO for the future replacement but at that moment when he was replacing eight leaders, he completely ignored this aspect.

5. Recalling Learning Styles Kolb, D. (Adapter, Divergent, Assimilator, Convergent) observe any developments in this regard in Sharper? Please, if so, indicate what evidence is.

Since the beginning, Sharer has been a doer rather than an observer. He enjoyed getting involved in details and giving his opinion. Over the period, as Sharer experienced different corporate environments with the unique set of values, he learnt a lot – particularly the importance of being an insider first before making considerable changes. 

Get instant access to this case solution for only $15

Get Instant Access to This Case Solution for Only $15

Standard Price

$25

Save $10 on your purchase

-$10

Amount to Pay

$15

Different Requirements? Order a Custom Solution

Calculate the Price

Approximately ~ 1 page(s)

Total Price

$0

Get More Out of This

Our essay writing services are the best in the world. If you are in search of a professional essay writer, place your order on our website.

Essay Writing Service
whatsapp chat icon

Hi there !

We are here to help. Chat with us on WhatsApp for any queries.

close icon